Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013		Jun. 30, 2012
Cash flows from operating activities
Net cash (used for) provided by operating activities	$ (8,554)		$ 5,178
Cash flows from investing activities
Capital expenditures for property, plant and equipment	(15,902)		(35,508)
Proceeds from sale of assets	15,448		1,192
Proceeds from sale of stock of Ferro Pfanstiehl Laboratories, Inc.	16,912
Dividends received from affiliates	1,119		436
Net cash provided by (used for) investing activities	17,577		(33,880)
Cash flows from financing activities
Net (repayments) borrowings under loans payable	(8,714)	[1]	34,906	[1]
Proceeds from revolving credit facility	216,201		212,996
Principal payments on revolving credit facility	(214,820)		(215,174)
Other financing activities	(387)		(1,060)
Net cash (used for) provided by financing activities	(7,720)		31,668
Effect of exchange rate changes on cash and cash equivalents	(217)		(590)
Increase in cash and cash equivalents	1,086		2,376
Cash and cash equivalents at beginning of period	29,576		22,991
Cash and cash equivalents at end of period	30,662		25,367
Cash paid during the period for:
Interest	13,396		13,196
Income taxes	$ 2,379		$ 2,098

[1] Includes cash flows related to our domestic accounts receivable program, international accounts receivable sales programs as well as loans payable to banks.